Patient group funding
Patient groups – non-profit organisations founded by patients, care-givers, family members and health professionals – are important stakeholders for GSK.
They engage with healthcare providers, governments, the media, and patients to promote improved treatment and services for patients. They also campaign on issues that affect patients’ and care-givers’ lives, including increasing access to quality medicines, services and information on disease. Some carry out research into the causes of and potential treatments for specific conditions.
Pan European
During 2019, we provided financial support to the following pan European patient groups:
Agora (PDF)
European Federation of Allergy and Airways Disease Patients Association (PDF)
European Patients’ Forum (PDF)
Lupus Europe (PDF)
Myeloma Patients Europe (PDF)
Pulmonary Hypertension Association Europe (PDF)
Back to top
National European
Details of funding provided to patient groups across Europe can be found on the relevant country website. Where no country website currently exists, and for those GSK local operating companies that supported patient groups in 2019, the information is either published directly on this page or in a booklet available from the local office.
Countries with websites
Austria
Czech Republic
France
Germany
Greece
Ireland
Italy
The Netherlands
Norway
Portugal
Romania
Spain
Sweden
Switzerland
Countries without websites
BeLux (PDF)
Bulgaria (PDF)
Croatia (PDF)
Hungary (PDF)
Israel (PDF)
Latvia (PDF)
Lithuania (PDF)
Romania (PDF)
Slovakia (PDF)
Slovenia (PDF)
UK
During 2019, we provided support to the following UK patient groups:
British Lung Foundation (PDF)
Meningitis Now (PDF)
Orchid (PDF)
Pulmonary Hypertension Association (PDF)
Positive Life (PDF)
Recovery Cymru (PDF)
Skcin (PDF)
Support in Mind (PDF)
GSK also provides funding to support UK community healthcare charities through the GSK IMPACT Awards, in partnership with The King’s Fund. This annual programme recognises and promotes excellence in community healthcare, providing funding and training to help strengthen the award winners’ current management plans and support their future aspirations. Find out more about our Impact Awards.
Back to topEmerging Markets and Intercontinental
During 2019 we provided funding to the following emerging markets and intercontinental patient groups:
Countries with websites
Australia
Brazil
Canada
Russia
South Korea
Turkey
Countries without websites
Argentina (PDF)
Chile (PDF)
Hong Kong (PDF)
Mexico (PDF)
New Zealand (PDF)
Taiwan (PDF)
Back to top
Global
During 2019, we provided financial support to the following global patient groups:
Confederation of Meningitis Organisations (CoMO) (PDF)
International Alliance of Patient Organisations (IAPO) (PDF)
Global Asthma and Allergy Patient Platform (GAAPP) (PDF)
Meningitis Research Foundation (PDF)
